Can a simple screening tool help nurses catch delirium in seniors?
NCT ID NCT05915377
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether daily nurse screening for delirium using a tool called UB-CAM can improve detection and reduce complications in hospitalized adults aged 70 and older. About 1,050 patients across three hospitals will take part. Researchers will measure how accurate the screening is and whether it leads to fewer falls, pressure injuries, or other problems.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- UB-CAM delirium screening tool integrated into electronic health records
- What this could lead to
- If successful, this could lead to better routine detection of delirium in hospitals, reducing falls and other complications for older patients.
- What could go wrong
- This is an implementation study, not a treatment trial. It may not show clear benefits, and screening accuracy depends on nurse training and adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,050 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2024
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
70 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * General medicine (hospitalist) service * Age 70 or older * Expected hospital length of stay of 3 or more days Exclusion Criteria: * Inability to communicate adequately in English * Admitted for terminal care
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Delirium are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Beth Israel Deaconness Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
-
Mount Nittany Medical Center
RECRUITINGState College, Pennsylvania, 16801, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a quieter, dimmer ICU protect Patients' brains?
- Can a daily supplement shield the brain after delirium?
- Brain surgery delirium: can real-time monitoring protect older patients?
- Could daylight hold the key to preventing delirium?
- Can sensory therapy calm Dementia-Related agitation in hospitals?
- A new care routine aims to shield aging hearts and minds in the ICU